Skip to main content
Clinical Trials/IRCT201101155612N1
IRCT201101155612N1
Completed
Phase 2

Evaluation of the effect of oral selenium administration on tremor reduction of Parkinsonians

Yazd University of Medical Sciences0 sites26 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Tremor.
Sponsor
Yazd University of Medical Sciences
Enrollment
26
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yazd University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusions: Idiopathic Parkinson disease; Age between 40 and 60 years; 6 months after diagnosis the disease; stage 2\.5 or less based on MODIFIED HOEHN AND YAHR STAGING 5 ; Apparent or troublesome tremor
  • Exclusions:Other disease induses tremor; out of age range between 40 to 60 years

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials